Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Protein-losing enteropathy: is it Crohn's disease?
Temido MJ, Lopes S, Figueiredo P, Portela F. Temido MJ, et al. Among authors: portela f. Rev Esp Enferm Dig. 2024 Apr 30. doi: 10.17235/reed.2024.10461/2024. Online ahead of print. Rev Esp Enferm Dig. 2024. PMID: 38685896 Free article.
An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management.
Oliveira CA, Mercês ÉAB, Portela FS, Malheiro LFL, Silva HBL, De Benedictis LM, De Benedictis JM, Silva CCDE, Santos ACL, Rosa DP, Velozo HS, de Jesus Soares T, de Brito Amaral LS. Oliveira CA, et al. Among authors: portela fs. Clin Exp Nephrol. 2024 Apr 27. doi: 10.1007/s10157-024-02490-x. Online ahead of print. Clin Exp Nephrol. 2024. PMID: 38678166 Review.
Compact RNA sensors for increasingly complex functions of multiple inputs.
Choe C, Andreasson JOL, Melaine F, Kladwang W, Wu MJ, Portela F, Wellington-Oguri R, Nicol JJ, Wayment-Steele HK, Gotrik M, Participants E, Khatri P, Greenleaf WJ, Das R. Choe C, et al. Among authors: portela f. bioRxiv [Preprint]. 2024 Jan 16:2024.01.04.572289. doi: 10.1101/2024.01.04.572289. bioRxiv. 2024. PMID: 38260323 Free PMC article. Preprint.
The influence of subclinical active inflammation on IFX pharmacokinetic modeling and disease progression assessment: findings from a prospective real-world study in inflammatory bowel disease patients.
Magro F, Fernandes S, Patita M, Arroja B, Lago P, Rosa I, de Sousa HT, Ministro P, Mocanu I, Vieira A, Castela J, Moleiro J, Roseira J, Cancela E, Sousa P, Portela F, Correia L, Moreira P, Dias S, Afonso J, Danese S, Peyrin-Biroulet L, Vucicevic KM, Santiago M. Magro F, et al. Among authors: portela f. J Crohns Colitis. 2024 Jan 19:jjae014. doi: 10.1093/ecco-jcc/jjae014. Online ahead of print. J Crohns Colitis. 2024. PMID: 38243908
Prophylactic versus endoscopy-driven treatment of Crohn's postoperative recurrence: A retrospective, multicentric European study (PORCSE study).
Geldof J, Truyens M, Hanssens M, Van Gucht E, Holvoet T, Elorza A, Bouillon V, Barros S, Martins V, Argyriou K, Potamianos S, Diculescu M, Stroie T, Bossuyt P, Moens A, Theodoraki E, Koutroubakis IE, Pedro J, Fernandes S, Nikolaou P, Karmiris K, Baert FJ, Ferreiro-Iglesias R, Peeters H, Claeys S, Casanova MJ, Eder P, Porter RJ, Arnott I, Karakan T, Mesonero F, Revés J, Van Dyck E, Jauregui-Amezaga A, Mañosa M, Rivière P, Marquez Mosquera L, Portela F, Pimentel R, Lobaton T. Geldof J, et al. Among authors: portela f. J Crohns Colitis. 2024 Jan 19:jjae011. doi: 10.1093/ecco-jcc/jjae011. Online ahead of print. J Crohns Colitis. 2024. PMID: 38243807
Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximab.
Sousa P, Patita M, Arroja B, Lago P, Rosa I, de Sousa HT, Ministro P, Mocanu I, Vieira A, Castela J, Moleiro J, Roseira J, Cancela E, Portela F, Correia L, Santiago M, Dias S, Alves C, Afonso J, Dias CC, Magro F. Sousa P, et al. Among authors: portela f. Dig Liver Dis. 2024 May;56(5):737-743. doi: 10.1016/j.dld.2023.10.027. Epub 2023 Nov 18. Dig Liver Dis. 2024. PMID: 37980274 Free article.
181 results